295 related articles for article (PubMed ID: 29051146)
1.
Chen TK; Tin A; Peralta CA; Appel LJ; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
Clin J Am Soc Nephrol; 2017 Nov; 12(11):1771-1777. PubMed ID: 29051146
[TBL] [Abstract][Full Text] [Related]
2. Patterns of Kidney Function Decline Associated with APOL1 Genotypes: Results from AASK.
Tin A; Grams ME; Estrella M; Lipkowitz M; Greene TH; Kao WHL; Li L; Appel LJ
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1353-1359. PubMed ID: 27230965
[TBL] [Abstract][Full Text] [Related]
3. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
Chen TK; Choi MJ; Kao WH; Astor BC; Scialla JJ; Appel LJ; Li L; Lipkowitz MS; Wolf M; Parekh RS; Winkler CA; Estrella MM; Crews DC
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2128-35. PubMed ID: 26430087
[TBL] [Abstract][Full Text] [Related]
4.
Chen TK; Appel LJ; Grams ME; Tin A; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1765-1769. PubMed ID: 28572159
[TBL] [Abstract][Full Text] [Related]
5. Race, APOL1 Risk Variants, and Clinical Outcomes among Older Adults: The ARIC Study.
Chen TK; Coresh J; Daya N; Ballew SH; Tin A; Crews DC; Grams ME
J Am Geriatr Soc; 2021 Jan; 69(1):155-163. PubMed ID: 32894582
[TBL] [Abstract][Full Text] [Related]
6. APOL1 risk variants, race, and progression of chronic kidney disease.
Parsa A; Kao WH; Xie D; Astor BC; Li M; Hsu CY; Feldman HI; Parekh RS; Kusek JW; Greene TH; Fink JC; Anderson AH; Choi MJ; Wright JT; Lash JP; Freedman BI; Ojo A; Winkler CA; Raj DS; Kopp JB; He J; Jensvold NG; Tao K; Lipkowitz MS; Appel LJ; ;
N Engl J Med; 2013 Dec; 369(23):2183-96. PubMed ID: 24206458
[TBL] [Abstract][Full Text] [Related]
7. Combined Effects of GSTM1 Null Allele and APOL1 Renal Risk Alleles in CKD Progression in the African American Study of Kidney Disease and Hypertension Trial.
Bodonyi-Kovacs G; Ma JZ; Chang J; Lipkowitz MS; Kopp JB; Winkler CA; Le TH
J Am Soc Nephrol; 2016 Oct; 27(10):3140-3152. PubMed ID: 26940095
[TBL] [Abstract][Full Text] [Related]
8. APOL1 Nephropathy Risk Alleles and Mortality in African American Adults: A Cohort Study.
Gutiérrez OM; Irvin MR; Zakai NA; Naik RP; Chaudhary NS; Estrella MM; Limou S; Judd SE; Cushman M; Kopp JB; Winkler CA
Am J Kidney Dis; 2020 Jan; 75(1):54-60. PubMed ID: 31563468
[TBL] [Abstract][Full Text] [Related]
9. APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV.
Jotwani V; Shlipak MG; Scherzer R; Parekh RS; Kao WH; Bennett M; Cohen MH; Nowicki M; Sharma A; Young M; Tien PC; Parikh CR; Estrella MM
Am J Kidney Dis; 2015 Jun; 65(6):889-98. PubMed ID: 25921719
[TBL] [Abstract][Full Text] [Related]
10. Plasma apolipoprotein L1 levels do not correlate with CKD.
Bruggeman LA; O'Toole JF; Ross MD; Madhavan SM; Smurzynski M; Wu K; Bosch RJ; Gupta S; Pollak MR; Sedor JR; Kalayjian RC
J Am Soc Nephrol; 2014 Mar; 25(3):634-44. PubMed ID: 24231663
[TBL] [Abstract][Full Text] [Related]
11. Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD.
Luo S; Coresh J; Tin A; Rebholz CM; Chen TK; Hayek SS; Tracy M; Lipkowitz MS; Appel LJ; Levey AS; Inker LA; Reiser J; Grams ME
Clin J Am Soc Nephrol; 2018 Jul; 13(7):1013-1021. PubMed ID: 29903900
[TBL] [Abstract][Full Text] [Related]
12. Race, APOL1 Risk, and eGFR Decline in the General Population.
Grams ME; Rebholz CM; Chen Y; Rawlings AM; Estrella MM; Selvin E; Appel LJ; Tin A; Coresh J
J Am Soc Nephrol; 2016 Sep; 27(9):2842-50. PubMed ID: 26966015
[TBL] [Abstract][Full Text] [Related]
13. Low prevalence of apolipoprotein L1 gene variants in Black South Africans with hypertension-attributed chronic kidney disease
.
Nqebelele NU; Dickens C; Dix-Peek T; Duarte R; Naicker S
Clin Nephrol; 2019 Jan; 91(1):40-47. PubMed ID: 30369398
[TBL] [Abstract][Full Text] [Related]
14.
Chaudhary NS; Moore JX; Zakai NA; Judd SE; Naik RP; Limou S; Cushman M; Lange LA; Wang HE; Winkler CA; Irvin MR; Kopp JB; Gutiérrez OM
Clin J Am Soc Nephrol; 2019 Dec; 14(12):1733-1740. PubMed ID: 31704668
[TBL] [Abstract][Full Text] [Related]
15. Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study.
Olivo RE; Davenport CA; Diamantidis CJ; Bhavsar NA; Tyson CC; Hall R; Bidulescu A; Young B; Mwasongwe SE; Pendergast J; Boulware LE; Scialla JJ
Nephrol Dial Transplant; 2018 Jun; 33(6):992-1001. PubMed ID: 28992354
[TBL] [Abstract][Full Text] [Related]
16.
Gutiérrez OM; Irvin MR; Chaudhary NS; Cushman M; Zakai NA; David VA; Limou S; Pamir N; Reiner AP; Naik RP; Sale MM; Safford MM; Hyacinth HI; Judd SE; Kopp JB; Winkler CA
Circ Genom Precis Med; 2018 Jun; 11(6):e002098. PubMed ID: 29899045
[TBL] [Abstract][Full Text] [Related]
17. Effect of Genetic African Ancestry on eGFR and Kidney Disease.
Udler MS; Nadkarni GN; Belbin G; Lotay V; Wyatt C; Gottesman O; Bottinger EP; Kenny EE; Peter I
J Am Soc Nephrol; 2015 Jul; 26(7):1682-92. PubMed ID: 25349204
[TBL] [Abstract][Full Text] [Related]
18. APOL1 Genotype and Race Differences in Incident Albuminuria and Renal Function Decline.
Peralta CA; Bibbins-Domingo K; Vittinghoff E; Lin F; Fornage M; Kopp JB; Winkler CA
J Am Soc Nephrol; 2016 Mar; 27(3):887-93. PubMed ID: 26180129
[TBL] [Abstract][Full Text] [Related]
19. Serum 6-Bromotryptophan Levels Identified as a Risk Factor for CKD Progression.
Tin A; Nadkarni G; Evans AM; Winkler CA; Bottinger E; Rebholz CM; Sarnak MJ; Inker LA; Levey AS; Lipkowitz MS; Appel LJ; Arking DE; Coresh J; Grams ME
J Am Soc Nephrol; 2018 Jul; 29(7):1939-1947. PubMed ID: 29777021
[No Abstract] [Full Text] [Related]
20.
Chen TK; Surapaneni AL; Arking DE; Ballantyne CM; Boerwinkle E; Chen J; Coresh J; Köttgen A; Susztak K; Tin A; Yu B; Grams ME
Clin J Am Soc Nephrol; 2022 May; 17(5):684-692. PubMed ID: 35474272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
